Daiwa Capital Downgrades Johnson & Johnson to Neutral, Lowers Price Target to $150
Author: Benzinga Newsdesk | July 23, 2024 05:35am
Daiwa Capital analyst Narumi Nakagiri downgrades Johnson & Johnson (NYSE:JNJ) from Outperform to Neutral and lowers the price target from $160 to $150.